Show simple item record

dc.contributor.authorIversen, Per Ole
dc.contributor.authorFrøyland, Livar
dc.contributor.authorHaugen, Margaretha
dc.contributor.authorHolvik, Kristin
dc.contributor.authorLøvik, Martinus
dc.contributor.authorStrand, Tor A
dc.contributor.authorTell, Grethe S.
dc.coverage.spatialNorwaynb_NO
dc.date.accessioned2018-04-27T11:38:29Z
dc.date.available2018-04-27T11:38:29Z
dc.date.created2017-10-19T09:53:03Z
dc.date.issued2016
dc.identifier.isbn978-82-8259-196-6
dc.identifier.urihttp://hdl.handle.net/11250/2496381
dc.description.abstractThe Norwegian Scientific Committee for Food Safety (VKM) has, at the request of the Norwegian Food Safety Authority, assessed the risk of specified doses of CLAs in food supplements. VKM concludes that: • In adults (≥18 years), the specified doses 3.0, 3.25 and 3.5 g/day CLAs in food supplements are considered to be unlikely to cause adverse health effects if used for up to six months. • CLA may cause lipid- and carbohydrate disturbances in obese men with metabolic syndrome as well as in overweight/obese subjects with type 2 diabetes. • Use of CLA supplements in lactating and pregnant women may cause reduction in milk production and in the content on milk fat and cause decreased birth weight andlength in their off-springs. • No conclusion can be made for children and adolescents. • Data are insufficient to conclude regarding use of CLAs for more than six months.nb_NO
dc.language.isoengnb_NO
dc.publisherNorwegian Committee for Food Safety (VKM)nb_NO
dc.relation.ispartofVKM Report
dc.relation.ispartofseriesVKM Report;
dc.relation.urihttps://vkm.no/download/18.645b840415d03a2fe8f2602a/1502797996894/e5f72e01ec.pdf
dc.rightsNavngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/deed.no*
dc.subjectAdverse health effectnb_NO
dc.subjectCLAnb_NO
dc.subjectconjugated linoleic acidnb_NO
dc.subjectfood supplementnb_NO
dc.subjectnegative health effectnb_NO
dc.subjectNorwegian Scientific Committee for Food Safetynb_NO
dc.subjectother substancesnb_NO
dc.subjectrisk assessmentnb_NO
dc.subjectVKMnb_NO
dc.titleRisk assessment of "other substances" - conjugated linoleic acids. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safetynb_NO
dc.typeResearch reportnb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber82nb_NO
dc.source.issue2016: 05nb_NO
dc.identifier.cristin1505791
cristin.unitcode1991,0,0,0
cristin.unitnameSykehuset Innlandet HF
cristin.ispublishedtrue
cristin.fulltextoriginal


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal